As the global economy mends, the 2021 growth of Tuberculosis Vaccination will have significant change from previous year. According to our (LP Information) latest study, the global Tuberculosis Vaccination market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Tuberculosis Vaccination market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.
The United States Tuberculosis Vaccination market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Tuberculosis Vaccination market, reaching US$ million by the year 2028. As for the Europe Tuberculosis Vaccination landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Tuberculosis Vaccination players cover Merck, Japan BCG Lab, Serum Institute of India, and AJ Vaccines, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Tuberculosis Vaccination market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Immune Vaccine
Therapy Vaccine
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Self-Procurement
UNICEF
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Merck
Japan BCG Lab
Serum Institute of India
AJ Vaccines
BioFarma
GreenSignal Bio Pharma
China National Biotec
Biomed Lublin
Taj Pharmaceuticals
Ataulpho de Paiva
IVAC - Institute of Vaccines and Medical Biologicals
Queen Saovabha Mem. Inst
Microgen
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Tuberculosis Vaccination Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Tuberculosis Vaccination by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Tuberculosis Vaccination by Country/Region, 2017, 2022 & 2028
2.2 Tuberculosis Vaccination Segment by Type
2.2.1 Immune Vaccine
2.2.2 Therapy Vaccine
2.3 Tuberculosis Vaccination Sales by Type
2.3.1 Global Tuberculosis Vaccination Sales Market Share by Type (2017-2022)
2.3.2 Global Tuberculosis Vaccination Revenue and Market Share by Type (2017-2022)
2.3.3 Global Tuberculosis Vaccination Sale Price by Type (2017-2022)
2.4 Tuberculosis Vaccination Segment by Application
2.4.1 Self-Procurement
2.4.2 UNICEF
2.4.3 Other
2.5 Tuberculosis Vaccination Sales by Application
2.5.1 Global Tuberculosis Vaccination Sale Market Share by Application (2017-2022)
2.5.2 Global Tuberculosis Vaccination Revenue and Market Share by Application (2017-2022)
2.5.3 Global Tuberculosis Vaccination Sale Price by Application (2017-2022)
3 Global Tuberculosis Vaccination by Company
3.1 Global Tuberculosis Vaccination Breakdown Data by Company
3.1.1 Global Tuberculosis Vaccination Annual Sales by Company (2020-2022)
3.1.2 Global Tuberculosis Vaccination Sales Market Share by Company (2020-2022)
3.2 Global Tuberculosis Vaccination Annual Revenue by Company (2020-2022)
3.2.1 Global Tuberculosis Vaccination Revenue by Company (2020-2022)
3.2.2 Global Tuberculosis Vaccination Revenue Market Share by Company (2020-2022)
3.3 Global Tuberculosis Vaccination Sale Price by Company
3.4 Key Manufacturers Tuberculosis Vaccination Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Tuberculosis Vaccination Product Location Distribution
3.4.2 Players Tuberculosis Vaccination Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Tuberculosis Vaccination by Geographic Region
4.1 World Historic Tuberculosis Vaccination Market Size by Geographic Region (2017-2022)
4.1.1 Global Tuberculosis Vaccination Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Tuberculosis Vaccination Annual Revenue by Geographic Region
4.2 World Historic Tuberculosis Vaccination Market Size by Country/Region (2017-2022)
4.2.1 Global Tuberculosis Vaccination Annual Sales by Country/Region (2017-2022)
4.2.2 Global Tuberculosis Vaccination Annual Revenue by Country/Region
4.3 Americas Tuberculosis Vaccination Sales Growth
4.4 APAC Tuberculosis Vaccination Sales Growth
4.5 Europe Tuberculosis Vaccination Sales Growth
4.6 Middle East & Africa Tuberculosis Vaccination Sales Growth
5 Americas
5.1 Americas Tuberculosis Vaccination Sales by Country
5.1.1 Americas Tuberculosis Vaccination Sales by Country (2017-2022)
5.1.2 Americas Tuberculosis Vaccination Revenue by Country (2017-2022)
5.2 Americas Tuberculosis Vaccination Sales by Type
5.3 Americas Tuberculosis Vaccination Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Tuberculosis Vaccination Sales by Region
6.1.1 APAC Tuberculosis Vaccination Sales by Region (2017-2022)
6.1.2 APAC Tuberculosis Vaccination Revenue by Region (2017-2022)
6.2 APAC Tuberculosis Vaccination Sales by Type
6.3 APAC Tuberculosis Vaccination Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Tuberculosis Vaccination by Country
7.1.1 Europe Tuberculosis Vaccination Sales by Country (2017-2022)
7.1.2 Europe Tuberculosis Vaccination Revenue by Country (2017-2022)
7.2 Europe Tuberculosis Vaccination Sales by Type
7.3 Europe Tuberculosis Vaccination Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Tuberculosis Vaccination by Country
8.1.1 Middle East & Africa Tuberculosis Vaccination Sales by Country (2017-2022)
8.1.2 Middle East & Africa Tuberculosis Vaccination Revenue by Country (2017-2022)
8.2 Middle East & Africa Tuberculosis Vaccination Sales by Type
8.3 Middle East & Africa Tuberculosis Vaccination Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Tuberculosis Vaccination
10.3 Manufacturing Process Analysis of Tuberculosis Vaccination
10.4 Industry Chain Structure of Tuberculosis Vaccination
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Tuberculosis Vaccination Distributors
11.3 Tuberculosis Vaccination Customer
12 World Forecast Review for Tuberculosis Vaccination by Geographic Region
12.1 Global Tuberculosis Vaccination Market Size Forecast by Region
12.1.1 Global Tuberculosis Vaccination Forecast by Region (2023-2028)
12.1.2 Global Tuberculosis Vaccination Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Tuberculosis Vaccination Forecast by Type
12.7 Global Tuberculosis Vaccination Forecast by Application
13 Key Players Analysis
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Tuberculosis Vaccination Product Offered
13.1.3 Merck Tuberculosis Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Japan BCG Lab
13.2.1 Japan BCG Lab Company Information
13.2.2 Japan BCG Lab Tuberculosis Vaccination Product Offered
13.2.3 Japan BCG Lab Tuberculosis Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Japan BCG Lab Main Business Overview
13.2.5 Japan BCG Lab Latest Developments
13.3 Serum Institute of India
13.3.1 Serum Institute of India Company Information
13.3.2 Serum Institute of India Tuberculosis Vaccination Product Offered
13.3.3 Serum Institute of India Tuberculosis Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Serum Institute of India Main Business Overview
13.3.5 Serum Institute of India Latest Developments
13.4 AJ Vaccines
13.4.1 AJ Vaccines Company Information
13.4.2 AJ Vaccines Tuberculosis Vaccination Product Offered
13.4.3 AJ Vaccines Tuberculosis Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 AJ Vaccines Main Business Overview
13.4.5 AJ Vaccines Latest Developments
13.5 BioFarma
13.5.1 BioFarma Company Information
13.5.2 BioFarma Tuberculosis Vaccination Product Offered
13.5.3 BioFarma Tuberculosis Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 BioFarma Main Business Overview
13.5.5 BioFarma Latest Developments
13.6 GreenSignal Bio Pharma
13.6.1 GreenSignal Bio Pharma Company Information
13.6.2 GreenSignal Bio Pharma Tuberculosis Vaccination Product Offered
13.6.3 GreenSignal Bio Pharma Tuberculosis Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 GreenSignal Bio Pharma Main Business Overview
13.6.5 GreenSignal Bio Pharma Latest Developments
13.7 China National Biotec
13.7.1 China National Biotec Company Information
13.7.2 China National Biotec Tuberculosis Vaccination Product Offered
13.7.3 China National Biotec Tuberculosis Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 China National Biotec Main Business Overview
13.7.5 China National Biotec Latest Developments
13.8 Biomed Lublin
13.8.1 Biomed Lublin Company Information
13.8.2 Biomed Lublin Tuberculosis Vaccination Product Offered
13.8.3 Biomed Lublin Tuberculosis Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Biomed Lublin Main Business Overview
13.8.5 Biomed Lublin Latest Developments
13.9 Taj Pharmaceuticals
13.9.1 Taj Pharmaceuticals Company Information
13.9.2 Taj Pharmaceuticals Tuberculosis Vaccination Product Offered
13.9.3 Taj Pharmaceuticals Tuberculosis Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Taj Pharmaceuticals Main Business Overview
13.9.5 Taj Pharmaceuticals Latest Developments
13.10 Ataulpho de Paiva
13.10.1 Ataulpho de Paiva Company Information
13.10.2 Ataulpho de Paiva Tuberculosis Vaccination Product Offered
13.10.3 Ataulpho de Paiva Tuberculosis Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Ataulpho de Paiva Main Business Overview
13.10.5 Ataulpho de Paiva Latest Developments
13.11 IVAC